BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Fresenius SE & Co KGaA

Cerrado

SectorSanidad

39.86 -0.2

Resumen

Variación precio

24h

Actual

Mínimo

39.7

Máximo

40.25

Métricas clave

By Trading Economics

Ingresos

-48M

271M

Ventas

264M

5.6B

P/B

Media del Sector

24.381

57.333

Margen de beneficios

4.813

Empleados

176,486

EBITDA

-33M

724M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+17.39% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.1B

22B

Apertura anterior

40.06

Cierre anterior

39.86

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Fresenius SE & Co KGaA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

26 feb 2025, 13:37 UTC

Charlas de Mercado

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5 jun 2024, 12:18 UTC

Charlas de Mercado

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Comparación entre iguales

Cambio de precio

Fresenius SE & Co KGaA previsión

Precio Objetivo

By TipRanks

17.39% repunte

Estimación a 12 Meses

Media 46.78 EUR  17.39%

Máximo 56.9 EUR

Mínimo 42 EUR

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fresenius SE & Co KGaA Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

13 ratings

11

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

39.5 / 39.92Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.